Investigation into Potent Inflammation Inhibitors from Traditional Chinese Medicine

ASIAIR > College of Medical and Health Science > Department of Biotechnology > Journal Article > Item 310904400/23390

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/23390

Title:	Investigation into Potent Inflammation Inhibitors from Traditional Chinese Medicine
Authors:	陳語謙;Chen, Calvin Yu-Chian
Contributors:	生物科技學系
Date:	2011
Issue Date:	2012-12-10 03:39:26 (UTC+0)
Abstract:	Investigation into Potent Inflammation Inhibitors from Traditional Chinese Medicine Microsomal prostaglandin E synthase-1 (mPGES-1) is the key enzyme for prostaglandin E2 (PGE2) generation during inflammation and is a potential target for designing anti-inflammatory drugs. Potential inhibitors of m-PGES-1 were selected from traditional Chinese medicine (TCM Database@Taiwan) based on the pharmacophore map generated by the top HypoGen hypothesis and validated using structure- and ligand-based analysis. Key features for potential m-PGES-1 inhibitors include pi-interactions and H-bond donors. TCM compounds, shanciol B, shanciol A, castilliferol, and aurantiamide acetate, contoured to the quantitative structure-activity relationship pharmacophore and exhibited high docking scores and binding stability with m-PGES-1. Bioactivity models multiple linear regression (MLR) and support vector machine also supported activity predictions for the candidate compounds. Our results indicate that the investigated TCM compounds could be of use for development into mPGES-1 inhibitors.
Appears in Collections:	[Department of Biotechnology] Journal Article

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	287	View/Open